Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brandes

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Agents and Actions. Supplements|January 1, 1991
The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liverL J Brandes, J R Davie, F Paraskevas, et al.
Cancer Treatment Reports|July 1, 1985
Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein-Barr virus antibody activityG J Goldenberg, L J Brandes, W H Lau, et al.
Science (New York, N.Y.)|March 24, 1989
Histamine is an intracellular messenger mediating platelet aggregationS P Saxena, L J Brandes, A B Becker, et al.
Cancer Research|July 15, 1988
Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylationL J Brandes, J M Gerrard, R P Bogdanovic, et al.
The Prostate|January 1, 1982
Retinoic acid binding protein in normal and neopolastic rat prostateM S Gesell, M J Brandes, E A Arnold, et al.
Biochemical Pharmacology|October 15, 1990
Histamine as an intracellular messengerL J Brandes, F S LaBella, G B Glavin, et al.
The Journal of Urology|October 12, 2005
Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastasesD Raghavan, L J Brandes, K Klapp, et al.
Cancer Research|July 1, 1992
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant dosesL J Brandes, R J Arron, R P Bogdanovic, et al.
Neurology|May 12, 2004
Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraineS Silberstein, S Tepper, J Brandes, et al.
Journal of the National Cancer Institute|May 18, 1994
Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlatesL J Brandes, R C Warrington, R J Arron, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Agents and Actions. Supplements|January 1, 1991
The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liverL J Brandes, J R Davie, F Paraskevas, et al.
Cancer Treatment Reports|July 1, 1985
Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein-Barr virus antibody activityG J Goldenberg, L J Brandes, W H Lau, et al.
Science (New York, N.Y.)|March 24, 1989
Histamine is an intracellular messenger mediating platelet aggregationS P Saxena, L J Brandes, A B Becker, et al.
Cancer Research|July 15, 1988
Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylationL J Brandes, J M Gerrard, R P Bogdanovic, et al.
The Prostate|January 1, 1982
Retinoic acid binding protein in normal and neopolastic rat prostateM S Gesell, M J Brandes, E A Arnold, et al.
Biochemical Pharmacology|October 15, 1990
Histamine as an intracellular messengerL J Brandes, F S LaBella, G B Glavin, et al.
The Journal of Urology|October 12, 2005
Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastasesD Raghavan, L J Brandes, K Klapp, et al.
Cancer Research|July 1, 1992
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant dosesL J Brandes, R J Arron, R P Bogdanovic, et al.
Neurology|May 12, 2004
Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraineS Silberstein, S Tepper, J Brandes, et al.
Journal of the National Cancer Institute|May 18, 1994
Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlatesL J Brandes, R C Warrington, R J Arron, et al.
Pageof 10